BioNTech (NASDAQ: BNTX) And Pfizer (NYSE: PFE) Files Petition Against CureVac BV (NASDAQ: CVAC) Over Patent Breach

Manufacturer of the COVID-19 vaccine BioNTech (NASDAQ: BNTX) and partner Pfizer (NYSE: PFE) announced on Tuesday that they had lodged a petition with the US District Court in Massachusetts, requesting for a ruling that their actions did not violate US patents claimed by rival CureVac BV (NASDAQ: CVAC). CureVac accused of trying to take advantage […]

Pfizer Inc. (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) Are Partnering on a Shingles mRNA Vaccine

Pfizer Inc. (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) have begun a new partnership to commercialize, develop, and research an mRNA vaccine for Shingles.  The disease, a form of the varicella-zoster virus, affects about 1 in 3 Americans. It affects people with cancer and those above the age of 50. It causes painful, disfiguring patches. […]

Pfizer Inc. (NYSE: PFE) and BioNTech SE’s (NASDAQ: BNTX) COVID-19 Vaccine Could Work Against Omicron

Pfizer Inc. (NYSE: PFE) and BioNTech SE’s (NASDAQ: BNTX) COVID-19 vaccine can protect against the omicron variant after two doses. This finding results from a study from Africa Health Research Institute, South Africa. The study shows that blood from people who had a previous infection and had taken two doses of the vaccine could protect […]

Pfizer Inc. (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) Seek FDA Approval for Boosters for Ages 16-18

Pfizer Inc. (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) will seek approval from the Food and Drug Administration (FDA) for a booster shot for teenagers aged 16-18 years. This announcement comes in the heels of Biden offering Americans assurance about the omicron strain of the coronavirus. Countries omicron has affected Experts have spotted the new […]

Pfizer Inc. (NYSE: PFE) Anticipating Vaccine Approval for Children Above 5, US Government Donates Vaccine to Nigeria

The US White House has informed governors to prepare for vaccination of children from five years from next month in anticipation of approval of Pfizer Inc. (NYSE: PFE) and BioNTech SE’s (NASDAQ: BNTX) COVID-19 vaccine for the age group in the coming weeks. Already the Biden administration has bought 65 million pediatric doses of the […]

Israeli Reveals the Pfizer Inc (NYSE: PFE) Covid Vaccine’s Effectiveness as Standing at 39% as the Delta Sting Grows More Severe

Israeli Health Ministry has its reservations about the Pfizer Inc (NYSE: PFE) and BioNTech SE – ADR (NASDAQ: BNTX) Covid-19 vaccine. The segment discloses that the vaccine is 39% effective in Israel. The effects of the Delta variant continue to be felt rather strongly in the country, but it is a good thing that the vaccine is helping in […]

The Covid Vaccine Market is a Long Game in the Early Innings (BNTX, AZN, DYAI, NVAX, MRNA, PFE, JNJ)

The Delta variant is surging as case numbers hit new highs in many countries around the world, including the US. One of the dynamics that has recently migrated to the center of the public debate is that surrounding so-called “breakthrough cases” – symptomatic Covid-19 infections among the already vaccinated. While hospitalizations and deaths among this […]